Publication | Open Access
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
137
Citations
9
References
2021
Year
Unknown Venue
Investigation B.1.617Viral DiagnosticsImmunologyCovid-19Emerging Infectious DiseaseInfection ControlVui Lineage B.1.617Public Health ExpertsDrastic RiseVaccinologyDiagnostic VirologyVaccine DevelopmentVirologyBbv152 VaccineesVirus ClassificationClinical MicrobiologyVaccinationEmerging Infectious DiseasesPathogenesisEmergent VirusMicrobiologyVaccine DesignMedicineVaccine Research
Abstract The drastic rise in the number of cases in Maharashtra, India has created a matter of concern for public health experts. Twelve isolates of VUI lineage B.1.617 were propagated in VeroCCL81 cells and characterized. Convalescent sera of the COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.
| Year | Citations | |
|---|---|---|
Page 1
Page 1